These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 15837240)
1. No evidence of cross-reactivity of human antibodies to a 33-mer peptide of the alpha-gliadin component of gluten with Bordetella pertussis pertactin. He Q; Viljanen MK; Hinkkanen AE; Arvilommi H; Mertsola J; Viander M Vaccine; 2005 May; 23(25):3336-40. PubMed ID: 15837240 [TBL] [Abstract][Full Text] [Related]
2. Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin. Hijnen M; He Q; Schepp R; Van Gageldonk P; Mertsola J; Mooi FR; Berbers GA Scand J Infect Dis; 2008; 40(2):94-104. PubMed ID: 17926203 [TBL] [Abstract][Full Text] [Related]
3. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190 [TBL] [Abstract][Full Text] [Related]
4. Serum antibodies against a 69-kilodalton outer-membrane protein, pertactin, from Bordetella pertussis in nonvaccinated children with and without a history of clinical pertussis. Trollfors B; Zackrisson G; Taranger J; Lagergård T J Pediatr; 1992 Jun; 120(6):924-6. PubMed ID: 1593352 [TBL] [Abstract][Full Text] [Related]
5. Role of pertactin in pertussis vaccines: the jury is still out. Desauziers E; Danve B; Decker MD; Veitch K J Infect Dis; 2004 Apr; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804 [No Abstract] [Full Text] [Related]
6. Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen. Hijnen M; Mooi FR; van Gageldonk PG; Hoogerhout P; King AJ; Berbers GA Infect Immun; 2004 Jul; 72(7):3716-23. PubMed ID: 15213111 [TBL] [Abstract][Full Text] [Related]
7. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209 [TBL] [Abstract][Full Text] [Related]
8. The preparation of A purified immunogenic pertactin from B. pertussis. El-Kady EM; Abu-Shady HM; Tohamy HS; Wahby AF Egypt J Immunol; 2007; 14(2):11-8. PubMed ID: 20306653 [TBL] [Abstract][Full Text] [Related]
9. Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. Mertsola J; Ruuskanen O; Kuronen T; Meurman O; Viljanen MK J Infect Dis; 1990 May; 161(5):966-71. PubMed ID: 2324547 [TBL] [Abstract][Full Text] [Related]
10. Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population. Lau RC N Z Med J; 1989 Oct; 102(878):560-2. PubMed ID: 2554227 [TBL] [Abstract][Full Text] [Related]
11. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough. Winsnes R; Lønnes T; Møgster B; Berdal BP Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124 [TBL] [Abstract][Full Text] [Related]
12. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. Nagel J; de Graaf S; Schijf-Evers D Dev Biol Stand; 1985; 61():325-30. PubMed ID: 2872120 [TBL] [Abstract][Full Text] [Related]
13. Impact of polymerase chain reaction on clinical pertussis research: Finnish and Swiss experiences. He Q; Schmidt-Schläpfer G; Just M; Matter HC; Nikkari S; Viljanen MK; Mertsola J J Infect Dis; 1996 Dec; 174(6):1288-95. PubMed ID: 8940220 [TBL] [Abstract][Full Text] [Related]
14. Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay. Zackrisson G; Krantz I; Lagergård T; Larsson P; Sekura R; Sigurs N; Taranger J; Trollfors B Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):149-54. PubMed ID: 2899027 [TBL] [Abstract][Full Text] [Related]
15. [Detection of antibody against Bordetella pertussis in whooping cough patients, healthy children and newborn infants. IgG, IgM and IgA antibody responses determined by enzyme-linked immunosorbent assay]. Miyata Y; Katsukawa C; Tanaka I; Harada K Kansenshogaku Zasshi; 1983 Jan; 57(1):7-16. PubMed ID: 6304209 [No Abstract] [Full Text] [Related]
16. Pertussis seroepidemiology in women and their infants in Sarlahi District, Nepal. Hughes MM; Englund JA; Edwards K; Yoder S; Tielsch JM; Steinhoff M; Khatry SK; LeClerq SC; Katz J Vaccine; 2017 Dec; 35(48 Pt B):6766-6773. PubMed ID: 29037576 [TBL] [Abstract][Full Text] [Related]
17. Comparison of recombinant and native pertactin of Bordetella pertussis. Xu Y; Zhang S; Bolgiano B; Tan Y; Asokanathan C; Zhang H; Xing D; Wang J Vaccine; 2011 Feb; 29(10):1974-80. PubMed ID: 21216309 [TBL] [Abstract][Full Text] [Related]
18. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Hendrikx LH; Schure RM; Oztürk K; de Rond LG; de Greeff SC; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Sep; 29(40):6874-80. PubMed ID: 21803088 [TBL] [Abstract][Full Text] [Related]
19. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. Hegerle N; Dore G; Guiso N Vaccine; 2014 Nov; 32(49):6597-600. PubMed ID: 25312274 [TBL] [Abstract][Full Text] [Related]
20. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. King AJ; Berbers G; van Oirschot HF; Hoogerhout P; Knipping K; Mooi FR Microbiology (Reading); 2001 Nov; 147(Pt 11):2885-95. PubMed ID: 11700340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]